Recalls / Active ingredient / Ranitidine Hydrochloride
Ranitidine Hydrochloride
7 FDA drug recalls involving the active ingredient “Ranitidine Hydrochloride”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2019-12-13 | Class II | RANITIDINE TABLETS, USP 150mg, 10,000-count bag, Country of Origin: INDIA NDC 62207-773-32 | Granules India Limited |
| 2019-11-22 | Class II | Ranitidine Tablets, USP 150 mg, 1000-count bottles, NDC 53746-253-10. | Amneal Pharmaceuticals, Inc. |
| 2019-11-22 | Class II | Ranitidine Tablets, USP 300 mg, 250-count bottles, NDC 53746-254-02. | Amneal Pharmaceuticals, Inc. |
| 2019-10-01 | Class II | Dr. Reddy's Ranitidine Tablets, USP 75 mg, 60 count bottles, NDC 55111-131-60, (OTC) | Dr. Reddy's Laboratories, Inc. |
| 2019-10-01 | Class II | Dr. Reddy's Ranitidine Capsules, USP 300 mg, a.) 30 count bottles (NDC 55111-130-30) b.) 100 count bottles (ND | Dr. Reddy's Laboratories, Inc. |
| 2019-10-01 | Class II | Dr. Reddy's: Ranitidine Capsules 150 mg, Rx a.) 60 count bottles (NDC 55111-129-60) b.) 500 count bottles (ND | Dr. Reddy's Laboratories, Inc. |
| 2019-10-01 | Class II | Dr. Reddy's Ranitidine Tablets, USP 150 mg, 24 count bottles, NDC 55111-404-34 (OTC) | Dr. Reddy's Laboratories, Inc. |